Editorial commentary: autologous chondrocyte implantation versus microfracture

Area of Science:

• Orthopedics and Regenerative Medicine
• Cartilage Repair Strategies

Background:

• Autologous chondrocyte implantation (ACI) is a cell-based therapy for articular cartilage defects.
• First-generation ACI utilized periosteum, while second-generation membrane-ACI (M-ACI) employs a synthetic or biological membrane.
• Microfracture is a common alternative surgical technique for cartilage repair.

Discussion:

• ACI demonstrates superior long-term outcomes and efficacy in treating larger cartilage lesions compared to microfracture.
• Membrane-ACI (M-ACI) offers technical advantages, including simplified surgical procedure and reduced incidence of problematic cartilage hypertrophy.
• The comparison highlights the evolution of ACI techniques towards improved clinical applicability and patient outcomes.

Key Insights:

• ACI provides greater durability and lower failure rates than microfracture for cartilage repair.
• M-ACI is technically simpler and has fewer cartilage hypertrophy complications than traditional ACI.
• Second-generation M-ACI shows promise but is not yet widely approved in the US.

Outlook:

• Further clinical evaluation and regulatory approval are anticipated for second-generation M-ACI.
• M-ACI may become a preferred treatment option for articular cartilage defects, especially larger ones.
• Continued research in cell-based therapies aims to enhance cartilage regeneration and functional recovery.